Sales of drugs in Turkey grew 17.7% to $1.72 billion last year, afterdeclining for the past few years because of the 1994 Turkish financial crisis, according to the country's Pharmaceutical Manufacturers Association, which noted that the industry in general continued to report losses, though at a reduced level.
The pharmaceutical industry had an average 3.6% loss in first-half 1997, compared to a loss of 4.4% in 1994, 7% in 1995 and 3.7% in 1996, according to association president Kaya Turgu, who told Reuters that the sector as a whole last showed a profit in 1993.
Mr Turgu blamed the Turkish price-control policy for the losses, and noted that the pharmaceutical industry is the only privately-owned but state-controlled sector in the country.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze